Overview
- 92 inspections across 82 sites are on record.
- 120 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-05-24.
At a glance
Inspections
92
Sites
82
Observations
120
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Zeid Kayali, M.D. | 24 May 2018 | Human Drugs | |
| Epaminondas Zakynthinos, M.D., PhD, Principal Investigator | 20 Apr 2018 | Human Drugs | |
| Peter Tenke, M.D., PhD, Principal Investigator | 13 Apr 2018 | Human Drugs | |
| Axis Clinical Trials | 4 Apr 2018 | Human Drugs | |
| Kara L. Calkins | 8 Mar 2018 | Human Drugs |
Sites inspected
Zeid Kayali, M.D.Rialto, United States1 insp.
Epaminondas Zakynthinos, M.D., PhD, Principal InvestigatorLarissa, Greece1 insp.
Peter Tenke, M.D., PhD, Principal InvestigatorBudapest X, Hungary1 insp.
Axis Clinical TrialsLos Angeles, United States1 insp.
Kara L. CalkinsLos Angeles, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Tara L Stockton3 shared
Diane C Van Leeuwen2 shared
Vashti E Bocker2 shared
Angela Shepas2 shared
James P Stallings2 shared
Binh T Nguyen1 shared
Richmond K Yip1 shared
Vickie L Anderson1 shared
Kimberly M Lichter1 shared
Naveen B Walker1 shared
Full investigator report
Get the verbatim findings behind Yvonne T Lacour's 120 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site